Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-10 · accession 0001415889-21-004370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-13 | 2021-09-10 | OLMA | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $29.38 | -5,251 | 1,790 | -75% | -$154.3K |
| D | 2021-09-13 | 2021-09-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,041 | +293% | +$10.8K |
| D | 2021-09-13 | 2021-09-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $0.00 | -5,251 | 173.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | S | D | 5,251 | $29.38 | 1,790 | D | — | — | (F2) The weighted average sale price for the transaction reported was $29.38, and the range of prices were between $29.01 and $29.59. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2021-09-10 | M | A | 5,251 | $2.06 | 7,041 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-10 | M | D | 5,251 | $0.00 | 173,293 | D | $2.06 · — to 2030-06-09 | 5,251 Common Stock | (F3) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. |